Stock listing

Abeona Therapeutics Inc.

Selected listing: A3DMHM · LS · EUR · DE

Abeona Therapeutics Inc. (Lang & Schwarz: A3DMHM), Health Technology. Latest release Oct 5, 2026: Abeona Therapeutics Announces New Employee Inducement Grants…

A3DMHM:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A3DMHM
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Abeona Therapeutics Inc.

Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)

October 5, 2026

Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)

September 18, 2026

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®

September 16, 2026

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

August 13, 2026

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

August 4, 2026

All Abeona Therapeutics Inc. news →

Events

Replays

Abeona Therapeutics Inc. (ABEO) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 08:30 AM ET
Watch
Abeona Therapeutics Inc. (ABEO) Q1 2026 Earnings Call
Wed, May 13, 2026 · 08:30 AM ET
Watch
Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call
Tue, Mar 17, 2026 · 08:30 AM ET
Watch

Research Abeona Therapeutics Inc.

Abeona Therapeutics Inc. company profile

View the public company page for Abeona Therapeutics Inc. on 6ix.

Abeona Therapeutics Inc. news

Read company news and market updates connected to Abeona Therapeutics Inc..

Abeona Therapeutics Inc. investor events

Find investor webinars, events, and replay context for Abeona Therapeutics Inc..